• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53在多形性腺瘤及多形性腺瘤癌变中的免疫组化表达

Immunohistochemical Expression of p53 in Pleomorphic Adenoma and Carcinoma Ex Pleomorphic Adenoma.

作者信息

Tarakji Bassel, Kujan Omar, Nassani Mohammad Z

机构信息

Department of Oral Pathology, Faculty of Dentistry, University of Aleppo, Aleppo, Syria.

出版信息

J Cancer Epidemiol. 2010;2010:250606. doi: 10.1155/2010/250606. Epub 2010 Dec 28.

DOI:10.1155/2010/250606
PMID:21253477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3022193/
Abstract

Context. Immunohistochemical stains for p53 are used as a diagnostic marker associated with malignancy in several histologic types of salivary gland tumors. This marker may be useful in differentiating pleomorphic adenoma (PA) from carcinoma ex pleomorphic adenoma (CPA), as these tumors are often difficult to distinguish on the basis of morphology alone. Objective. to evaluate whatever inactivation of tumor suppressor gene (p53) increases with the tumor progression from normal salivary tissue to PA and eventually CPA. Design. Paraffin blocks of 29 cases of PA, which were surrounded by normal parotid gland, and 27 cases of carcinoma ex pleomorphic adenoma were retrieved and validated. In all cases of carcinoma ex pleomorphic adenoma, a PA "ghost" was identified, and the malignant element was either undifferentiated carcinoma or adenocarcinoma. Results. The results showed negative nuclear expression of P53 in normal parotid gland. Nuclear P53 was expressed strongly in 6/29 (20.7%) pleomorphic salivary adenoma and 10/27 (37%) carcinoma ex pleomorphic adenoma. Conclusion. Our data suggest that inactivation of p53 may play an important role in the evolution of pleomorphic salivary adenoma and carcinoma ex pleomorphic adenoma.

摘要

背景。p53免疫组化染色在多种组织学类型的涎腺肿瘤中用作与恶性肿瘤相关的诊断标志物。该标志物在鉴别多形性腺瘤(PA)和多形性腺瘤恶变(CPA)时可能有用,因为这些肿瘤通常仅根据形态学难以区分。目的。评估肿瘤抑制基因(p53)失活是否随肿瘤从正常涎腺组织发展为多形性腺瘤并最终发展为多形性腺瘤恶变而增加。设计。检索并验证了29例被正常腮腺组织包绕的多形性腺瘤石蜡块以及27例多形性腺瘤恶变病例。在所有多形性腺瘤恶变病例中,均识别出一个多形性腺瘤“残影”,恶性成分要么是未分化癌,要么是腺癌。结果。结果显示正常腮腺组织中P53呈阴性核表达。核P53在6/29(20.7%)的多形性腺瘤和10/27(37%)的多形性腺瘤恶变中呈强表达。结论。我们的数据表明,p53失活可能在多形性腺瘤和多形性腺瘤恶变的演变中起重要作用。

相似文献

1
Immunohistochemical Expression of p53 in Pleomorphic Adenoma and Carcinoma Ex Pleomorphic Adenoma.p53在多形性腺瘤及多形性腺瘤癌变中的免疫组化表达
J Cancer Epidemiol. 2010;2010:250606. doi: 10.1155/2010/250606. Epub 2010 Dec 28.
2
The expression of FHIT in salivary carcinoma ex pleomorphic adenoma.涎腺多形性腺瘤恶变中 FHIT 的表达
Anticancer Res. 2012 Aug;32(8):3147-52.
3
Expression of p21 is dependent on or independent of p53 in carcinoma ex pleomorphic adenoma (undifferentiated and adenocarcinoma types).在多形性腺瘤癌变(未分化型和腺癌型)中,p21的表达依赖或不依赖于p53。
Pol J Pathol. 2012 Dec;63(4):286-91. doi: 10.5114/pjp.2012.32778.
4
Immunohistochemical evaluation of androgen receptor, HER-2/neu, and p53 in benign pleomorphic adenomas.良性多形性腺瘤中雄激素受体、HER-2/neu和p53的免疫组织化学评估
Arch Pathol Lab Med. 2008 Dec;132(12):1907-11. doi: 10.5858/132.12.1907.
5
Immunohistochemical expression of p21 in normal tissues of salivary gland, pleomorphic adenoma and carcinoma ex pleomorphic adenoma-(undifferentiated and adenocarcinoma types).p21 在唾液腺正常组织、多形性腺瘤和癌在多形性腺瘤中的免疫组织化学表达-(未分化型和腺癌型)。
Med Oral Patol Oral Cir Bucal. 2010 Sep 1;15(5):e697-703. doi: 10.4317/medoral.15.e697.
6
[Carcinoma ex pleomorphic adenoma of major salivary glands--a clinicopathologic review].[大唾液腺多形性腺瘤癌变——临床病理综述]
Otolaryngol Pol. 2007;61(5):687-93. doi: 10.1016/S0030-6657(07)70507-3.
7
Transformation of pleomorphic adenoma to carcinoma ex pleomorphic adenoma of the parotid gland is independent of p53 mutations.腮腺多形性腺瘤向癌在多形性腺瘤中的转化与 p53 突变无关。
J Surg Oncol. 2010 Feb 1;101(2):127-30. doi: 10.1002/jso.21444.
8
HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma.HMGA2 是多形性腺瘤和癌在多形性腺瘤中的特异性免疫组化标志物。
Histopathology. 2017 Oct;71(4):511-521. doi: 10.1111/his.13246. Epub 2017 Jul 5.
9
Recurrent rearrangements of the PLAG1 and HMGA2 genes in lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma.PLAG1 和 HMGA2 基因在泪腺多形性腺瘤和癌在多形性腺瘤中的反复重排。
Acta Ophthalmol. 2018 Nov;96(7):e768-e771. doi: 10.1111/aos.13667. Epub 2018 Feb 13.
10
Carcinoma ex pleomorphic adenoma: A diagnostic challenge on cytology.多形性腺瘤恶变:细胞学诊断的一项挑战。
Diagn Cytopathol. 2017 Jul;45(7):651-654. doi: 10.1002/dc.23704. Epub 2017 Mar 6.

引用本文的文献

1
Immunohistochemical profiling of Bcl-2 and EGFR proteins in cervical carcinoma at a tertiary hospital in Ghana.加纳一家三级医院宫颈癌中Bcl-2和表皮生长因子受体(EGFR)蛋白的免疫组织化学分析
Niger Med J. 2025 Jun 16;66(2):575-585. doi: 10.71480/nmj.v66i2.713. eCollection 2025 Mar-Apr.
2
Immunohistochemical expression of p16 in Carcinoma Ex-pleomorphic Adenoma (undifferentiated and Adenocarcinoma Types).多形性腺瘤癌变(未分化型和腺癌型)中p16的免疫组化表达
J Clin Diagn Res. 2013 Dec;7(12):3054-6. doi: 10.7860/JCDR/2013/7380.3851. Epub 2013 Dec 15.
3
GSK3β and CREB3 gene expression profiling in benign and malignant salivary gland tumors.

本文引用的文献

1
Carcinoma ex pleomorphic adenoma of soft palate with cavernous sinus invasion.软腭癌型多形性腺瘤伴海绵窦侵袭。
World J Surg Oncol. 2010 Mar 30;8:24. doi: 10.1186/1477-7819-8-24.
2
Parotid glands tumours: overview of a 10-year experience with 282 patients, focusing on 231 benign epithelial neoplasms.腮腺肿瘤:282例患者10年经验概述,重点关注231例良性上皮性肿瘤。
Eur Rev Med Pharmacol Sci. 2008 Sep-Oct;12(5):321-5.
3
Peroxiredoxin I, platelet-derived growth factor A, and platelet-derived growth factor receptor alpha are overexpressed in carcinoma ex pleomorphic adenoma: association with malignant transformation.
良性和恶性涎腺肿瘤中GSK3β和CREB3基因表达谱分析
Iran Biomed J. 2012;16(3):140-4. doi: 10.6091/IBJ.1050.2012.
过氧化物酶体增殖物激活受体I、血小板衍生生长因子A和血小板衍生生长因子受体α在多形性腺瘤癌变中过表达:与恶性转化相关。
Hum Pathol. 2009 Mar;40(3):390-7. doi: 10.1016/j.humpath.2008.06.030. Epub 2008 Nov 7.
4
[Malignant mixed tumor].[恶性混合瘤]
Gan To Kagaku Ryoho. 2004 Mar;31(3):314-7.
5
Expression and mutation patterns of p53 in benign and malignant salivary gland tumors.
Int J Oncol. 2000 Mar;16(3):477-83. doi: 10.3892/ijo.16.3.477.
6
Proliferative activity as detected by immunostaining with Ki-67 and proliferating cell nuclear antigen in benign and malignant epithelial lesions of the human parotid gland.通过Ki-67免疫染色和增殖细胞核抗原检测人腮腺良性和恶性上皮性病变中的增殖活性。
Anal Quant Cytol Histol. 1999 Aug;21(4):336-42.
7
Expression of p53 and p21CIP1/WAF1 proteins in oral epithelial dysplasias and squamous cell carcinomas.p53和p21CIP1/WAF1蛋白在口腔上皮发育异常和鳞状细胞癌中的表达
Oncol Rep. 1999 May-Jun;6(3):539-45. doi: 10.3892/or.6.3.539.
8
Deletion of the p16 gene and microsatellite instability in carcinoma arising in pleomorphic adenoma of the parotid gland.
Diagn Mol Pathol. 1998 Aug;7(4):224-31. doi: 10.1097/00019606-199808000-00007.
9
DNA analysis at p53 locus in carcinomas arising from pleomorphic adenomas of salivary glands: comparison of molecular study and p53 immunostaining.涎腺多形性腺瘤来源的癌中p53基因座的DNA分析:分子研究与p53免疫染色的比较
Pathol Int. 1998 Apr;48(4):265-72. doi: 10.1111/j.1440-1827.1998.tb03904.x.
10
p16INK4, pRB, p53 and cyclin D1 expression and hypermethylation of CDKN2 gene in thymoma and thymic carcinoma.胸腺瘤和胸腺癌中p16INK4、pRB、p53和细胞周期蛋白D1的表达以及CDKN2基因的高甲基化
Int J Cancer. 1997 Nov 27;73(5):639-44. doi: 10.1002/(sici)1097-0215(19971127)73:5<639::aid-ijc5>3.0.co;2-y.